Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?

CNS Neuroscience and Therapeutics

Volumn 17, Issue 2, 2011, Pages 83-88

  Keller, William R ^a   Fischer, Bernard A ^a,b   Carpenter, William T ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

Author keywords

Diagnosis; Dimensions; Psychoses; Schizophrenia

Indexed keywords

CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HEBEPHRENIA; HUMAN; PARANOID SCHIZOPHRENIA; PERCEPTION DISORDER; REVIEW; SCHIZOPHRENIA;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PSYCHIATRY; SCHIZOPHRENIA;

EID: 79952649217     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00229.x     Document Type: Review

References (77)

1. Mack AH, Forman L, Brown R, Frances A. A brief history of psychiatric classification. From the ancients to DSM-IV. Psychiatr Clin North Am 1994;17:515-523.
2. Kraepelin E. Dementia praecox and paraphrenia. New York Krieger, 1971. [First published, 1919.]
3. Blueler E. Dementia praecox or the group of schizophrenias. New York International Universities Press, 1950. [First Published, 1911.]
4. Langfeldt G. Diagnosis and prognosis of schizophrenia. Proc R Soc Med 1960;53:51-56.
5. Langfeldt G. The diagnosis of schizophrenia. Am J Psychiatry 1951;108:123-125.
6. Schneider K. Clinical psychopathology.Hamilton MW, translator. New York Grune & Stratton, 1959.
7. Mellor CS. First rank symptoms of schizophrenia. I. The frequency in schizophrenics on admission to hospital. II. Differences between individual first rank symptoms. Br J Psychiatry 1970;117:15-23.
8. Carpenter WT Jr., Strauss JS, Muleh S. Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry 1973;28:847-852.
9. American psychiatric association: Diagnostic and statistical manual of mental disorders, 1st ed., Washington American Psychiatric Association, 1952.
10. American psychiatric association: Diagnostic and statistical manual of mental disorders, 2nd ed., Washington American Psychiatric Association, 1968.
11. Kendell RE, Cooper JE, Gourlay AJ, Copeland JR, Sharpe L, Gurland BJ. Diagnostic criteria of American and British psychiatrists. Arch Gen Psychiatry 1971;25:123-130.
12. American psychiatric association: Diagnostic and statistical manual of mental disorders, 4th ed., Text Revision. Washington, DC American Psychiatric Association, 2000.
13. Bell V, Halligan PW, Ellis HD. Diagnosing delusions: A review of inter-rater reliability Schizophr Res 2006;86:76-79.
14. Cermolacce M, Sass L, Parnas J. What is bizarre in bizarre delusions? Crit Rev Schizophr Bull 2010;36:667-679.
15. Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull 2010;36:239-242.
16. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 2010;36:314-320.
17. Carpenter WT, Strauss JS. Cross-cultural evaluation of Schneider's first rank symptoms of schizophrenia: A report from the International Pilot Study of Schizophrenia. Am J Psychiatry 1974;131:682-687.
18. Strauss JS, Carpenter WT Jr., Bartko JJ. An approach to the diagnosis and understanding of schizophrenia: Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974;11:61-79.
19. Carpenter WT, Strauss JS, Muleh S. Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Kurt Schneider's first rank symptoms. Arch Gen Psychiatry 1973;28:847-852.
20. Hawk AB, Carpenter WT Jr., Strauss JS. Diagnostic criteria and five-year outcome in schizophrenia. A report from the International Pilot Study of schizophrenia. Arch Gen Psychiatry 1975;32:343-347.
21. Strauss JS, Carpenter WT. Characteristic symptoms and outcome in schizophrenia. Arch Gen Psychiatry 1974;30:117-120.
22. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: A report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry 1974;31:37-42.
23. Carpenter WT, Strauss JS, Bartko JJ: A flexible system for the identification of schizophrenia: A report from the International Pilot Study of Schizophrenia. Science 1973b;182:1275-1278.
24. Carpenter WT Jr., Bartko JJ, Strauss JS, Hawk AB. Signs and symptoms as predictors of outcome: A report from the International Pilot Study of Schizophrenia. Am J Psychiatry 1978;135:940-945.
25. Moller HJ, Bottlender R, Gross A, Hoff P, Wittmann J, Wegner U, Strauss A. The Kraepelinian dichotomy: Preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr Res 2002;56:87-94.
26. Strauss GP, Harrow M, Grossman LS, Rosen C. Periods of recovery in deficit syndrome schizophrenia: A 20-year multi-follow-up longitudinal study. Schizophr Bull 2010;36:788-799.
27. Andreasen NC, Carpenter WT Jr., Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441-449.
28. Fischer BA, Carpenter WT. Remission. In: Mueser KM, Jeste DV, editors. Clinical handbook of schizophrenia New York Guilford Press, 2008;559-565.
29. Roe D, Davidson L. Recovery. In: Mueser KM, Jeste DV, editors. Clinical handbook of schizophrenia New York Guilford Press, 2008;566-574.
30. Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry 2002;14:256-272.
31. Harrow M, Jobe TH. How frequent is chronic multiyear delusional activity and recovery in schizophrenia: A 20-year multi-follow-up. Schizophr Bull 2010;36:192-204.
32. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull 2005;31:723-734.
33. Marengo J. Classifying the courses of schizophrenia. Schizophr Bull 1994;20:519-536.
34. Andreason NC, Olsen S Negative v positive schizophrenia: Definition and validation. Arch Gen Psychiatry 1982b;39:789-794.
35. Andreason NC Positive vs. negative schizophrenia: A critical evaluation. Schizophr Bull 1985;11:380-389.
36. Crow TJ. Molecular pathology of schizophrenia: More than one disease process? Br Med J 1980;280:66-86.
37. Crow TJ. The two-syndrome concept: Origins and current status. Schizophr Bull 1985;11:471-486.
38. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001;58:165-171.
39. Carpenter WT Jr., Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: The concept. Am J Psychiatry 1988;145:578-583.
40. Kirkpatrick B, Amador XF, Flaum M, et al. The deficit syndrome in the DSM-IV Field Trial, I: Alcohol and other drug abuse. Schizophr Res 1996;20:69-77.
41. Fenton WS, McGlashan TH. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry 1994;151:351-356.
42. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr. Depressive symptoms and the deficit syndrome of schizophrenia. J Nerv Ment Dis 1994;182:452-455.
43. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT Jr. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry 1990;147:290-294.
44. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 1994;51:804-811.
45. Kirkpatrick B, Buchanan RW. The neural basis of the deficit syndrome of schizophrenia. J Nerv Ment Dis 1990;178:545-555.
46. Messias E, Kirkpatrick B, Bromet E, et al. Summer birth and deficit schizophrenia: A pooled analysis from 6 countries. Arch Gen Psychiatry 2004;61:985-989.
47. Kirkpatrick B, Herrera Castanedo S, Vazquez-Barquero JL. Summer birth and deficit schizophrenia: Cantabria, Spain. J Nerv Ment Dis 2002;190:526-532.
48. Kirkpatrick B, Tek C, Allardyce J, Morrison G, McCreadie RG. Summer birth and deficit schizophrenia in Dumfries and Galloway, southwestern Scotland. Am J Psychiatry 2002;159:1382-1387.
49. Tek C, Kirkpatrick B, Kelly C, McCreadie RG. Summer birth and deficit schizophrenia in Nithsdale, Scotland. J Nerv Ment Dis 2001;189:613-617.
50. Messias E, Kirkpatrick B. Summer birth and deficit schizophrenia in the epidemiological catchment area study. J Nerv Ment Dis 2001;189:608-612.
51. Kirkpatrick B, Castle D, Murray RM, Carpenter WT Jr. Risk factors for the deficit syndrome of schizophrenia. Schizophr Bull 2000;26:233-242.
52. Kirkpatrick B, Ram R, Amador XF, Buchanan RW, McGlashan T, Tohen M, Bromet E. Summer birth and the deficit syndrome of schizophrenia. Am J Psychiatry 1998;155:1221-1226.
53. Kirkpatrick B, Messias NC, Conley RR, Roberts RC. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis 2003;191:563-567.
54. Kirkpatrick B, Conley RC, Kakoyannis A, Reep RL, Roberts RC. Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: An unbiased cell-counting study. Synapse 1999;34:95-102.
55. Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ. Gray-matter abnormalities in deficit schizophrenia. Schizophr Res 2010;120:63-70.
56. Rowland LM, Spieker EA, Francis A, Barker PB, Carpenter WT, Buchanan RW. White matter alterations in deficit schizophrenia. Neuropsychopharmacology 2009;34:1514-1522.
57. Galderisi S, Quarantelli M, Volpe U, et al. Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull 2008;34:393-401.
58. Gonul AS, Kula M, Esel E, Tutus A, Sofuoglu S. A Tc-99m HMPAO SPECT study of regional cerebral blood flow in drug-free schizophrenic patients with deficit and non-deficit syndrome. Psychiatry Res: Neuroimaging 2003;123:199-205.
59. Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT Jr. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry 2001;158:1797-1808.
60. Sigmundsson T, Suckling J, Maier M, et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 2001;158:234-243.
61. Heckers S, Goff D, Schacter DL, et al. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch Gen Psychiatry. 1999;56:1117-1123.
62. Turetsky B, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry 1995;52:1061-1070.
63. Buchanan RW, Breier A, Kirkpatrick B, et al. Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993;150:59-65.
64. Tamminga CA, Thaker GK, Buchanan R, et al. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992;49:522-530.
65. Dollfus S, Ribeyre JM, Petit M. Family history and deficit form in schizophrenia. Eur Psychiatry 1996;11:260-262.
66. Dollfus S, Germain-Robin S, Chabot B, et al. Family history and obstetric complications in deficit and non-deficit schizophrenia: Preliminary results. Eur Psychiatry 1998;13:270-272.
67. Kirkpatrick B, Ross DE, Walsh D, Karkowski L, Kendler KS Family characteristics of the deficit and nondeficit schizophrenia in the Roscommon family study. Schizophr Res 2000b;45:57-64.
68. Ross DE, Kirkpatrick B, Karkowski LM, et al. Sibling correlation of deficit syndrome in the Irish Study of high-density schizophrenia families. Am J Psychiatry 2000;157:1071-1076.
69. Kirkpatrick B, Mitchell BD, DeLisi LE. Concordance of the deficit/nondeficit categorization in affected siblings. Schizophr Bull 2007;33:282.
70. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, Murray R. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med 1999;29:595-606.
71. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001;49:269-285.
72. Cuesta MJ, Peralta V. Psychopathological dimensions in schizophrenia. Schizophr Bull 1995;21:473-482.
73. Buchanan RW, Davis M, Goff D, et al. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005;31:5-19.
74. Kirkpatrick B, Fenton WS, Carpenter WT Jr., Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006;32:214-219.
75. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: Findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009;35:894-908.
76. Heckers S. Who is at risk for a psychotic disorder? Schizophr Bull 2009;35:847-850.
77. American psychiatric association: DSM-5 development. Available from: (Accessed 3 August 2010).